<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M329</article-id>
      <article-id pub-id-type="publisher-id">molbank-2003-M329</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>5-{4-Nitro-3-[1-(toluene-4-sulphonyl)-hexyl]-phenyl}-10,15,20-triphenylporphyrin Zinc(II)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ostrowski</surname>
            <given-names>Stanislaw</given-names>
          </name>
          <xref rid="af1-molbank-2003-M329" ref-type="aff">a</xref>
          <xref rid="af2-molbank-2003-M329" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mikus</surname>
            <given-names>Agnieszka</given-names>
          </name>
          <xref rid="af1-molbank-2003-M329" ref-type="aff">a</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2003-M329"><label>a</label>Institute of Chemistry, University of Podlasie, ul. 3 Maja 54, PL-08-110 Siedlce, Poland; E-mail: <email>stan@ap.siedlce.pl</email></aff>
      <aff id="af2-molbank-2003-M329"><label>b</label>Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, PL-01-224 Warszawa, Poland; E-mail: <email>stan@icho.edu.pl</email></aff>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>05</month>
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2003</year>
      </pub-date>
      <volume>2003</volume>
      <issue>3</issue>
      <elocation-id>M329</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>04</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>04</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2003 MDPI.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <license>
          <p>All rights reserved.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Tetraphenylporphyrin derivatives</kwd>
        <kwd>Carbanions</kwd>
        <kwd>Sulphones</kwd>
        <kwd>Alkylation</kwd>
        <kwd>Zinc</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>As part of ongoing research programme we synthesised the title <italic>meso</italic>-tetraarylporphyrin derivative possessing a high degree of complexity in one phenyl ring. This compound is valuable potential intermediate for reactions, leading to biologically active porphyrins, such as PDT agents.<sup><xref ref-type="bibr" rid="B1-molbank-2003-M329">1</xref>)</sup> We used for this purpose the Vicarious Nucleophilic Substitution of Hydrogen reaction (VNS)<sup><xref ref-type="bibr" rid="B2-molbank-2003-M329">2</xref>)</sup> and subsequent alkylation of the intermediate <bold>2</bold> by n-pentyl iodide.</p>
	  <p><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2003-M329-i001.tif"/></p>
      <p>To a stirred solution of <italic>t</italic>-BuOK (87 mg, 0.78 mmol) in anhydrous DMSO (2.5 ml, under argon) a solution of 5-(4-nitrophenyl)-10,15,20-triphenylporphyrin zinc(II)<sup><xref ref-type="bibr" rid="B3-molbank-2003-M329">3</xref>)</sup> (<bold>1</bold>; 79 mg, 0.11 mmol) and chloromethyl <italic>para</italic>-tolyl sulphone (45 mg, 0.22 mmol) in DMSO (1.5 ml) was added dropwise <italic>via</italic> syringe at room temp. during <italic>ca</italic> 5 min. After additional 30 min of stirring the mixture was poured into 3% HCl containing ice (30 ml). The precipitate was filtered, washed with water, and then dissolved in CHCl<sub>3</sub>. After drying with anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporation of the solvent the 5-[4-nitro-3-(toluene-4-sulphonylmethyl)-phenyl]-10,15,20-triphenylporphyrin zinc(II) (<bold>2</bold>; described in earlier literature<sup><xref ref-type="bibr" rid="B3-molbank-2003-M329">3</xref>)</sup>) was isolated by column chromatography (silica gel 200-300 mesh, Merck AG; eluent: CHCl<sub>3</sub>/n-hexane - 3:1); yield - 86 mg, 88%.</p>
      <p>In a round-bottom flask (10 ml), the solution of 5-[4-nitro-3-(toluene-4-sulphonylmethyl)-phenyl]-10,15,20-triphenylporphyrin zinc(II) (<bold>2</bold>; 86 mg, 0.096 mmol) in DMF (2.5 ml) was cooled to 0&#xB0;C. Then, <italic>t</italic>-BuOK (45 mg, 0.40 mmol) was added in a one portion and the mixture was stirred for 15 min under argon. To this mixture, 1-iodopentane (79 mg, 0.40 mmol) in DMF (1 ml) was added at 0&#xB0;C. The reaction was continued at this temp. for <italic>ca</italic> 3 h until completion (TLC monitoring; CHCl<sub>3</sub>/n-hexane - 3:1). The mixture was poured onto water with ice (40 ml), the product was extracted with CHCl<sub>3</sub> (3 x 10 ml), and the organic layer was washed with H<sub>2</sub>O (2 x 20 ml). After drying over MgSO<sub>4</sub> and evaporation of the solvent, the crude product was purified by column chromatography (silica gel 200-300 mesh, Merck AG) using CH<sub>2</sub>Cl<sub>2</sub>/n-hexane mixture (1:1) as eluent. Yield of pure deep-purple solid 5-{4-nitro-3-[1-(toluene-4-sulphonyl)-hexyl]-phenyl}-10,15,20-triphenylporphyrin zinc(II) (<bold>3</bold>) - 77 mg (83%).</p>
    <sec>
      <title>5-[4-Nitro-3-(toluene-4-sulphonylmethyl)-phenyl]-10,15,20-triphenylporphyrin Zinc(II) (2):</title>
      <p>M.p. &gt; 300&#xB0;C.</p>
      <p><sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz): 9.02 (d, J = 4.8 Hz, 2 H, H<sup>&#x3B2;</sup>-pyrrole), 8.98 (s, 4 H, H<sup>&#x3B2;</sup>-pyrrole), 8.83 (d, J = 4.8 Hz, 2 H, H<sup>&#x3B2;</sup>-pyrrole), 8.37 (s, 1 H, H-Ar(NO<sub>2</sub>)), 8.30-8.17 (m, 8 H, 2 H of H-Ar(NO<sub>2</sub>) and 6 H of H-Ph), 7.84-7.68 (m, 9 H, H-Ph), 7.66 (apparent d, J = 8.5 Hz, 2 H, H-Tol), 7.38 (apparent d, J = 8.5 Hz, 2 H, H-Tol), 5.08 (s, 2 H, CH<sub>2</sub>), 2.29 (s, 3 H, CH<sub>3</sub>).</p>
      <p>UV-VIS (CH<sub>2</sub>Cl<sub>2</sub>), &#x3BB;<sub>max</sub> (log &#x3B5;): 590 (3.62), 549 (4.02), 420 (5.19, Soret), 348 nm (3.90).</p>
      <p>MS (EI), m/z (% rel. int.): 893 (21), 891 (27), 889 (34) [isotopic M<sup>+&#xB7;</sup>], 739 (3), 737 (5), 735 (9), 723 (6), 721 (10), 719 (15), 691 (9), 613 (5), 306 (4), 299 (4), 173 (14), 156 (14), 139 (10), 106 (15), 92 (52), 91 (100), 77 (10), 65 (27), 64 (53).</p>
      <p>HR-MS (EI) Calcd for C<sub>52</sub>H<sub>35</sub>N<sub>5</sub>O<sub>4</sub>SZn: 889.1701; Found: 889.1699.</p>
    </sec>
    <sec>
      <title>5-{4-Nitro-3-[1-(toluene-4-sulphonyl)-hexyl]-phenyl}-10,15,20-triphenylporphyrin Zinc(II) (3):</title>
      <p>M.p. &gt; 300&#xB0;C.</p>
      <p>IR (neat, cm<sup>-1</sup>): 3103, 3055 &amp; 3021 (CH<sub>aromat</sub><sub>.</sub>); 2956, 2921 &amp; 2850 (CH<sub>3</sub>, CH<sub>2</sub>); 1597; 1524 &amp; 1340 (NO<sub>2</sub>); 1320 &amp; 1147 (SO<sub>2</sub>).</p>
      <p><sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz): 9.11 (d, J = 4.8 Hz, 1 H, H<sup>&#x3B2;</sup>-pyrrole), 9.02-8.95 (m, 3 lines, 6 H, H<sup>&#x3B2;</sup>-pyrrole), 8.77 (d, J = 4.6 Hz, 1 H, H<sup>&#x3B2;</sup>-pyrrole), 8.66 (d, J = 1.7 Hz, 1 H, H-Ar(NO<sub>2</sub>)), 8.30 (part of AB coupled with another proton, J = 8.3, 1.7 Hz, 1 H, H-Ar(NO<sub>2</sub>)), 8.28-8.19 (m, 6 H, H-Ph), 8.18 (part of AB, J = 8.3 Hz, 1 H, H-Ar(NO<sub>2</sub>)), 7.83-7.73 (m, 9 H, H-Ph), 7.70 (apparent d, J = 8.2 Hz, 2 H, H-Tol), 7.33 (apparent d, J = 8.2 Hz, 2 H, H-Tol), 5.69 (dd, J = 10.8, 4.2 Hz, 1 H, CH(SO<sub>2</sub>Tol)), 2.50-2.38 (m, 2 H, CH<sub>2</sub>), 2.41 (s, 3 H, CH<sub>3</sub>-Tol), 1.37-1.22 (m, 6 H, 3xCH<sub>2</sub>), 0.85 (t, J = 6.9 Hz, 3 H, CH<sub>3</sub>).</p>
      <p>UV-VIS (CHCl<sub>3</sub>), &#x3BB;<sub>max</sub> (log &#x3B5;): 596.5 (3.56), 556 (4.09), 518 (3.38), 423.5 (5.39, Soret), 356 (3.90), 333 nm (4.10).</p>
      <p>LSIMS(+), m/z (% rel. int.): 961 (2), 960 (3, M+H), 959 (3), 958 (3), 803 (2), 601 (2), 523 (3), 395 (7), 369 (3), 307 (12), 154 (100).</p>
      <p>Elemental analysis calcd. for C<sub>57</sub>H<sub>45</sub>N<sub>5</sub>SO<sub>4</sub>Zn (961.46): C - 71.21, H - 4.72, N - 7.28. Found: C - 70.75, H - 5.26, N - 6.32.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="app1-molbank-2003-M329">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2003-M329-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2003-M329-s001-mod.mol"><label>Supplementary File 1</label></supplementary-material>
        <supplementary-material id="molbank-2003-M329-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2003-M329-s001.mol"><label>Supplementary File 2</label></supplementary-material>
      </app>
    </app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2003-M329">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsi</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Glatstein</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <source>Drugs</source>
          <year>1999</year>
          <volume>57</volume>
          <fpage>725</fpage>
          <pub-id pub-id-type="pmid">10353297</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2003-M329">
        <label>2.</label>
        <citation citation-type="journal">
        <label>a)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Makosza</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wojciechowski</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <source>Liebigs Ann. / Recueil</source>
          <year>1997</year>
          <fpage>1805</fpage>
        </citation>
        <citation citation-type="journal">
        <label>b)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Ostrowski</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>Y.K.</given-names>
            </name>
          </person-group>
          <source>Bull. Korean Chem. Soc.</source>
          <year>2001</year>
          <volume>22</volume>
          <fpage>9</fpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2003-M329">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ostrowski</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mikus</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.-Ch.</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>E.-Y.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K.-I.</given-names>
            </name>
            <name>
              <surname>Olejnik</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Heterocycles</source>
          <year>2002</year>
          <volume>57</volume>
          <fpage>1615</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
